Arrowhead Research (ARWR) Ends 1Q with $77M to Focus on HBV and AAT; Piper Jaffray Reiterates Overweight
Go back to Arrowhead Research (ARWR) Ends 1Q with $77M to Focus on HBV and AAT; Piper Jaffray Reiterates Overweight| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 67.99 +2.20 (3.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $65.79 | 52 Week High | $8.22 | |||
| Open | $68.91 | 52 Week Low | $3.07 | |||
| Day High | $68.91 | P/E | N/A | |||
| Day Low | $67.00 | EPS | $-1.30 | |||
| Volume | 1,629,992 | |||||
